Mesoblast

MESO

MESO Mesoblast NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    MESO Chart
    See on advanced chart >

    About

    Mesoblast Limited was incorporated on June 8, 2004 in Australia. The company is a world leader in developing allogeneic cellular medicines. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad...
    • Highlight
      A global leader in allogeneic cellular medicines for inflammatory diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      11/13/2015
    • Established Date
      06/08/2004
    • Full-time Employees
      83
    • Address
      Level 38 55 Collins Street Melbourne VIC 3000 Australia
    • Tel
      61-3-96396036
    • Website
    • Fiscal Year End Date
      06/30
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-04-21 05:01:05